143 related articles for article (PubMed ID: 18547472)
1. Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase.
Ferdinande L; Demetter P; Perez-Novo C; Waeytens A; Taildeman J; Rottiers I; Rottiers P; De Vos M; Cuvelier CA
Int J Immunopathol Pharmacol; 2008; 21(2):289-95. PubMed ID: 18547472
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease.
Zhou L; Chen H; Wen Q; Zhang Y
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):695-701. PubMed ID: 22387885
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease.
Wolf AM; Wolf D; Rumpold H; Moschen AR; Kaser A; Obrist P; Fuchs D; Brandacher G; Winkler C; Geboes K; Rutgeerts P; Tilg H
Clin Immunol; 2004 Oct; 113(1):47-55. PubMed ID: 15380529
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
[TBL] [Abstract][Full Text] [Related]
5. Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.
Ciorba MA; Bettonville EE; McDonald KG; Metz R; Prendergast GC; Newberry RD; Stenson WF
J Immunol; 2010 Apr; 184(7):3907-16. PubMed ID: 20181893
[TBL] [Abstract][Full Text] [Related]
6. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
7. Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.
Paveglio SA; Allard J; Foster Hodgkins SR; Ather JL; Bevelander M; Campbell JM; Whittaker LeClair LA; McCarthy SM; van der Vliet A; Suratt BT; Boyson JE; Uematsu S; Akira S; Poynter ME
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):11-23. PubMed ID: 20118221
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice.
Gurtner GJ; Newberry RD; Schloemann SR; McDonald KG; Stenson WF
Gastroenterology; 2003 Dec; 125(6):1762-73. PubMed ID: 14724829
[TBL] [Abstract][Full Text] [Related]
9. IDO1 plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Hatano Y; Tomita H; Kuno T; Saito K; Hara A
J Immunol; 2013 Sep; 191(6):3057-64. PubMed ID: 23956437
[TBL] [Abstract][Full Text] [Related]
10. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.
Murakami Y; Hoshi M; Hara A; Takemura M; Arioka Y; Yamamoto Y; Matsunami H; Funato T; Seishima M; Saito K
Cytokine; 2012 Aug; 59(2):245-51. PubMed ID: 22609210
[TBL] [Abstract][Full Text] [Related]
12. Bifidobacteria alleviate experimentally induced colitis by upregulating indoleamine 2, 3-dioxygenase expression.
Zhao L; Suolang Y; Zhou D; Tang Y; Zhang Y
Microbiol Immunol; 2018 Feb; 62(2):71-79. PubMed ID: 29226383
[TBL] [Abstract][Full Text] [Related]
13. Induction of epithelial arachidonate 12-lipoxygenase at active sites of inflammatory bowel disease.
Shannon VR; Stenson WF; Holtzman MJ
Am J Physiol; 1993 Jan; 264(1 Pt 1):G104-11. PubMed ID: 7679252
[TBL] [Abstract][Full Text] [Related]
14. A paradoxical pattern of indoleamine 2,3-dioxygenase expression in the colon tissues of patients with acute graft-versus-host disease.
Park G; Choi YJ; Lee SE; Lim JY; Lee C; Choi EY; Min CK
Exp Hematol; 2014 Sep; 42(9):734-40. PubMed ID: 24732701
[TBL] [Abstract][Full Text] [Related]
15. Indoleamine-pyrrole 2,3-dioxygenase-1 (IDO-1) mRNA is over-expressed in the duodenal mucosa and is negatively correlated with serum tryptophan concentrations in dogs with protein-losing enteropathy.
Kathrani A; Lezcano V; Hall EJ; Jergens AE; Seo YJ; Mochel JP; Atherly T; Allenspach K
PLoS One; 2019; 14(6):e0218218. PubMed ID: 31181125
[TBL] [Abstract][Full Text] [Related]
16. Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.
Alvarado DM; Chen B; Iticovici M; Thaker AI; Dai N; VanDussen KL; Shaikh N; Lim CK; Guillemin GJ; Tarr PI; Ciorba MA
Gastroenterology; 2019 Oct; 157(4):1093-1108.e11. PubMed ID: 31325428
[TBL] [Abstract][Full Text] [Related]
17. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of indoleamine 2,3-dioxygenase in Helicobacter pylori-infected human gastric mucosa modulates Th1/Th2 pathway and interleukin 17 production.
Larussa T; Leone I; Suraci E; Nazionale I; Procopio T; Conforti F; Abenavoli L; Hribal ML; Imeneo M; Luzza F
Helicobacter; 2015 Feb; 20(1):41-8. PubMed ID: 25308308
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas.
von Bubnoff D; Scheler M; Wilms H; Wenzel J; von Bubnoff N; Häcker G; Schultze J; Popov A; Racz P; Bieber T; Wickenhauser C
J Am Acad Dermatol; 2011 Oct; 65(4):819-832. PubMed ID: 21501890
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease.
Fonseca-Camarillo G; Furuzawa-Carballeda J; Yamamoto-Furusho JK
Cytokine; 2015 Oct; 75(2):389-402. PubMed ID: 26141420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
